Dynavax Technologies Corporation (DVAX)
Feb 10, 2026 - DVAX was delisted (reason: acquired by SNY)
15.50
0.00 (0.00%)
Inactive · Last trade price on Feb 9, 2026
Dynavax Technologies Employees
Dynavax Technologies had 405 employees as of December 31, 2024. The number of employees decreased by 3 or -0.74% compared to the previous year.
Employees
405
Change (1Y)
-3
Growth (1Y)
-0.74%
Revenue / Employee
$816,084
Profits / Employee
-$107,163
Market Cap
1.76B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 405 | -3 | -0.74% |
| Dec 31, 2023 | 408 | 57 | 16.24% |
| Dec 31, 2022 | 351 | 40 | 12.86% |
| Dec 31, 2021 | 311 | 66 | 26.94% |
| Dec 31, 2020 | 245 | 14 | 6.06% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
DVAX News
- 21 days ago - Ciena Set to Join S&P 500; Arrowhead Pharmaceuticals to Join S&P MidCap 400; ADT and OneSpaWorld Holdings to Join S&P SmallCap 600 - PRNewsWire
- 2 months ago - Shares of Dynamax Are Up Nearly 40% Today. Here's Why The Stock Is Flying - Investopedia
- 2 months ago - This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. - Barrons
- 2 months ago - Sanofi to acquire Dynavax for $2.2B, sending shares higher by 37% - Invezz
- 2 months ago - Sanofi to acquire US biotech Dynavax for $2.2 billion - Reuters
- 2 months ago - Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal - WSJ
- 2 months ago - Sanofi to Acquire Dynavax, Adding a Marketed Adult Hepatitis B Vaccine and Phase 1/2 Shingles Candidate to the Pipeline - PRNewsWire
- 2 months ago - Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline - GlobeNewsWire